REVIEW ARTICLES Dobutamine Stress Myocardial Perfusion Imaging
暂无分享,去创建一个
[1] F. Fernández‐Avilés,et al. Selection of the optimal stress test for the diagnosis of coronary artery disease , 1998, Heart.
[2] Jeroen J. Bax,et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] D. Dione,et al. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] M. Takeuchi,et al. Is dobutamine-induced sinus node deceleration a marker of significant stenosis of the right coronary artery? , 1998, Chest.
[5] Jeroen J. Bax,et al. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy , 1997, European Journal of Nuclear Medicine.
[6] W. Smith,et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing. , 1997, Circulation.
[7] D. DeLong,et al. Analysis of cardiac arrhythmias during dobutamine pharmacologic stress testing in nuclear cardiology as related to the presence or absence of baseline arrhythmias , 1997, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[8] D. Waters,et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. , 1997, The American journal of cardiology.
[9] Y. T. Lee,et al. Simultaneous dobutamine stress echocardiography and thallium-201 perfusion imaging for the detection of coronary artery disease. , 1997, Cardiology.
[10] J R Roelandt,et al. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. , 1997, Journal of the American College of Cardiology.
[11] A. Salustri,et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? , 1997, Circulation.
[12] L. Tokgozoglu,et al. Effect of an additional atropine injection during dobutamine infusion for myocardial SPET. , 1997, Nuclear medicine communications.
[13] J. Roelandt,et al. Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. , 1997, The American journal of cardiology.
[14] J. Seward,et al. Paradoxical sinus deceleration during dobutamine stress echocardiography: description and angiographic correlation. , 1997, Journal of the American College of Cardiology.
[15] L. Tokgozoglu,et al. Dobutamine thallium-201 myocardial SPECT in patients with left bundle branch block and normal coronary arteries. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] P. Rigo,et al. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy. , 1997, Cardiovascular surgery.
[17] R. Senior,et al. Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease. , 1996, The American journal of cardiology.
[18] M. Verani,et al. Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging , 1996, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[19] M. Verani,et al. Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging? , 1996, Journal of the American College of Cardiology.
[20] M. Verani,et al. Simultaneous perfusion tomography and radionuclide angiography during dobutamine stress. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] J. Roelandt,et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. , 1996, Journal of the American College of Cardiology.
[22] J. Cornel,et al. Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. , 1996, The American journal of cardiology.
[23] D. Giorgi,et al. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease , 1996, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[24] E. Raftery,et al. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients. , 1996, European heart journal.
[25] J. Deckers,et al. Optimal pharmacological stress testing for the diagnosis of coronary artery disease: a probabilistic approach. , 1995, European heart journal.
[26] J. Ball,et al. Evaluation of 99Tcm‐tetrofosmin as a myocardial perfusion agent in routine clinical use , 1995, Nuclear medicine communications.
[27] J. Roelandt,et al. Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. , 1995, The American journal of cardiology.
[28] G. Mairesse,et al. Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography. , 1995, The American journal of cardiology.
[29] A. Weyman,et al. Effect of β-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography , 1995 .
[30] J. Kisslo,et al. Hypotension during dobutamine stress echocardiography: is it related to dynamic intraventricular obstruction? , 1995, American heart journal.
[31] P. Shah,et al. Mechanisms of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. , 1995, The American journal of cardiology.
[32] R. Pai,et al. Normal changes in left ventricular filling and hemodynamics during dobutamine stress echocardiography. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[33] R. Waugh,et al. Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment? , 1995, American heart journal.
[34] J. Machac,et al. Dobutamine thallium 201 perfusion imaging in candidates for lung transplantation. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[35] A. Weyman,et al. Effect of hydration on cavity obliteration during dobutamine stress echocardiography , 1995, Clinical cardiology.
[36] R. Gibbons,et al. Sinus node deceleration during dobutamine perfusion scintigraphy as a marker of inferior ischemia. , 1994, The American journal of cardiology.
[37] G. Mairesse,et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. , 1994, Journal of the American College of Cardiology.
[38] E. Raftery,et al. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. , 1994, American heart journal.
[39] S. Chae,et al. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] A. Salustri,et al. Chrome congestive heart failureAtropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers , 1994 .
[41] S. Steel,et al. Dipyridamole is superior to dobutamine for thallium stress imaging: a randomised crossover study. , 1994, British heart journal.
[42] K. Labresh,et al. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. , 1994, The American journal of cardiology.
[43] I. Coma-Canella,et al. The dobutamine stress test with thallium-201 single-photon emission computed tomography and radionuclide angiography: postinfarction study. , 1993, Journal of the American College of Cardiology.
[44] T. Marwick,et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? , 1993, Journal of the American College of Cardiology.
[45] M. Verani,et al. Therapeutic significance of exercise-induced ST-segment elevation in patients without previous myocardial infarction. , 1993, The American journal of cardiology.
[46] G. Vetrovec,et al. Assessment of thallium scintigraphy and echocardiography during dobutamine infusion for the detection of coronary artery disease. , 1993, Catheterization and cardiovascular diagnosis.
[47] A. Salustri,et al. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. , 1993, Journal of the American College of Cardiology.
[48] E. Oztürk,et al. Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[49] M. Verani,et al. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. , 1993, Journal of the American College of Cardiology.
[50] H. Schelbert,et al. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. , 1993, The American journal of cardiology.
[51] D. Pennell,et al. Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. , 1993, The American journal of cardiology.
[52] W. Mathias,et al. Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. , 1993, Journal of the American College of Cardiology.
[53] T. Marwick,et al. Selection of the Optimal Nonexercise Stress for the Evaluation of Ischemic Regional Myocardial Dysfunction and Malperfusion Comparison of Dobutamine and Adenosine Using Echocardiography and 99mTc‐MIBI Single Photon Emission Computed Tomography , 1993, Circulation.
[54] R. Gibbons,et al. Sinus node deceleration during exercise as a marker of significant narrowing of the right coronary artery. , 1993, The American journal of cardiology.
[55] K. Bailey,et al. Dynamic Intraventricular Obstruction During Dobutamine Stress Echocardiography: A New Observation , 1992, Circulation.
[56] A. Salustri,et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.
[57] C. Oakley,et al. Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. , 1992, The American journal of cardiology.
[58] L. Crouse,et al. Hypotension during dobutamine stress echocardiography: initial description and clinical relevance. , 1992, American heart journal.
[59] D. Pennell,et al. Dobutamine thallium myocardial perfusion tomography. , 1991, Journal of the American College of Cardiology.
[60] I. Coma‐Canella. Dobutamine stress test to diagnose the presence and severity of coronary artery lesions in angina. , 1991, European heart journal.
[61] I. Coma-Canella,et al. Changes in plasma potassium during the dobutamine stress test. , 1991, International journal of cardiology.
[62] F. Harrell,et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. , 1989, JAMA.
[63] V. Froelicher,et al. Exercise-induced hypotension in a male population. Criteria, causes, and prognosis. , 1988, Circulation.
[64] R. Ruffolo. ReviewReview: The Pharmacology of Dobutamine , 1987 .
[65] A. Buda,et al. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. , 1987, Circulation.
[66] H. Black,et al. Thallium-201 stress imaging in hypertensive patients. , 1987, Hypertension.
[67] R. Nesto,et al. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. , 1987, The American journal of cardiology.
[68] B. Chaitman. The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease. , 1986, Journal of the American College of Cardiology.
[69] Mark E. Williams,et al. Catecholamine modulation of rapid potassium shifts during exercise. , 1985, The New England journal of medicine.
[70] H. Loeb,et al. Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. , 1984, American heart journal.
[71] O. Hess,et al. Thallium-201 scintigraphy in complete left bundle branch block. , 1984, The American journal of cardiology.
[72] G. Diamond,et al. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.
[73] F. Orzan,et al. Is the treadmill exercise test useful for evaluating coronary artery disease in patients with complete left bundle branch block? , 1978, The American journal of cardiology.
[74] D. Twieg,et al. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. , 1976, The American journal of cardiology.
[75] D. Pennell,et al. Whole-Body Imaging of Thal!ium-201 After Six Different Stress Regimens , 2006 .
[76] P. Chieng,et al. Do β-blockers affect the diagnostic sensitivity of dobutamine stress thallium-201 single photon emission computed tomographic imaging? , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[77] R. Sciagrà,et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[78] Jeroen J. Bax,et al. Comparison of dobutamine stress echocardiography and 99m-technetium sestamibi SPECT myocardial perfusion scintigraphy for predicting extent of coronary artery disease in patients with healed myocardial infarction. , 1997, The American journal of cardiology.
[79] A. Salustri,et al. Safety and feasibility of dobutamine-atrophine stress echocardiography in patients with ischemic left ventricular dysfunction , 1996 .
[80] T. Marwick. Current status of non-invasive techniques for the diagnosis of myocardial ischemia. , 1992, Acta clinica Belgica.
[81] A. Mark. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. , 1983, Journal of the American College of Cardiology.